First Quadrant’s Abiomed Inc ABMD Stock Holding History

First Quadrant’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-89	Closed	-$25K	–	695
2020 Q3	$25K	Hold	89	–	–	﹤0.01%	528
2020 Q2	$21K	Sell	89 -3,901	-98%	-$783K	﹤0.01%	679
2020 Q1	$579K	Hold	3,990	–	–	0.08%	239
2019 Q4	$681K	Hold	3,990	–	–	0.06%	276
2019 Q3	$710K	Hold	3,990	–	–	0.07%	269
2019 Q2	$1.04M	Hold	3,990	–	–	0.07%	301
2019 Q1	$1.14M	Hold	3,990	–	–	0.09%	242
2018 Q4	$1.3M	Hold	3,990	–	–	0.1%	199
2018 Q3	$1.79M	Hold	3,990	–	–	0.04%	317
2018 Q2	$1.63M	Sell	3,990 -1,378	-26%	-$499K	0.03%	351
2018 Q1	$1.56M	Sell	5,368 -1,106	-17%	-$280K	0.03%	353
2017 Q4	$1.21M	Hold	6,474	–	–	0.02%	410
2017 Q3	$1.09M	Hold	6,474	–	–	0.02%	426
2017 Q2	$928K	Sell	6,474 -2,126	-25%	-$286K	0.02%	439
2017 Q1	$1.08M	Hold	8,600	–	–	0.02%	445
2016 Q4	$969K	Hold	8,600	–	–	0.02%	445
2016 Q3	$1.11M	Hold	8,600	–	–	0.02%	416
2016 Q2	$940K	Buy	+8,600	New	+$856K	0.02%	392

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

First Quadrant's ABMD Position: Q4 2020 in Review

First Quadrant sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 89 shares — an estimated $25K sold.

First Quadrant first reported a position in ABMD in Q2 2016 and held it in 18 quarters. The position peaked at $1.79M in Q3 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

First Quadrant reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
First Quadrant sold 89 Abiomed Inc shares in Q4 2020, an estimated $25K.
First Quadrant first reported a position in Abiomed Inc in Q2 2016 and held it in 18 quarters.
First Quadrant's Abiomed Inc position peaked at $1.79M in Q3 2018.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on First Quadrant's 13F filing for Q4 2020, filed 27 Jan 2021.